<DOC>
	<DOC>NCT00513201</DOC>
	<brief_summary>OBJECTIVE: To compare lispro insulin and regular insulin in the glycemic control of patients with liver cirrhosis and type 2 diabetes subjects. METHODS: 108 patients with liver cirrhosis and type 2 diabetes were randomly treated with regular insulin or lispro. After 122 weeks a cross-over was carried out and patients followed-up for 122 weeks. Then, all patients received a standard breakfast of 145 kcal following 12 U.I. of regular insulin or lispro, and C-peptide and insulin serum levels were determined over 300 minutes.</brief_summary>
	<brief_title>Lyspro Insulin vs Regular Insulin in Cirrhotic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>Insulintreated diabetes mellitus and liver cirrhosis Oral hypoglycemic agents treated diabetes mellitus Liver cancer</criteria>
	<gender>All</gender>
	<minimum_age>48 Years</minimum_age>
	<maximum_age>67 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>lyspro</keyword>
	<keyword>regular insulin</keyword>
	<keyword>cirrhotic patients</keyword>
</DOC>